This website uses cookies
Read our Privacy policy and Terms of use for more information.
All Posts
/
Sep 28, 2026
PLUS: The HealthTech Signal Plus: Stentless Cath Lab Economics & Receptor Subtype Neurology
Sep 26, 2026
PLUS: Inside the Once-Weekly Metabolic Shift & Outpatient Cardiology Economics
Sep 25, 2026
PLUS: Why Early-Line Disease Modification Changes Healthcare Valuation Multiples
Sep 24, 2026
PLUS: Inside the MCED Diagnostic Cascade & Generic Radiopharmaceutical Economics
Sep 23, 2026
PLUS: FDA clears MICSI-PET AI and Ultragenyx wins landmark gene therapy approval
Sep 22, 2026
PLUS: The $10,000 cath lab false alarm calculus, oral SERD companion diagnostic moats, and crossover trial biology.
Sep 21, 2026
PLUS: Why sentence-level provenance is pharma's new RWE moat
Sep 18, 2026
PLUS: Altis Labs $25M for AI endpoints and Sling's $123M oral TED pill
Sep 17, 2026
PLUS: What the De Novo classification means for every hospital's liability exposure
